Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer
患有妇科和乳腺癌的育龄妇女的产科和肿瘤结果
基本信息
- 批准号:10481831
- 负责人:
- 金额:$ 22.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-18 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:37 weeks gestationAddressAgeAmbulatory Surgical ProceduresAmerican Society of Clinical OncologyAssisted Reproductive TechnologyAwardBirthCaliforniaCancer SurvivorCenters for Disease Control and Prevention (U.S.)CharacteristicsClinicCohort StudiesComplementConceptionsCounselingCross-Sectional StudiesDataData SetData SourcesDatabasesDecision MakingDevelopmentDevelopment PlansDiagnosisDiscipline of obstetricsDiseaseDistressEconomicsEndometrialEndometrial CarcinomaFertilityFollow-Up StudiesFoundationsFundingFutureGestational AgeGoalsGynecologic OncologistHealth PlanningHealth ServicesHormonal ChangeHospital RecordsKnowledgeLinkLive BirthLow Birth Weight InfantMalignant Female Reproductive System NeoplasmMalignant NeoplasmsMalignant neoplasm of cervix uteriMalignant neoplasm of ovaryMeasuresMethodological StudiesMicroscopicObservational StudyOperative Surgical ProceduresOutcomeOvarianPatientsPhysiciansPopulationPostpartum PeriodPregnancyPregnancy OutcomePregnancy RatePremature BirthQuality of CareRadiation therapyRecording of previous eventsRecurrenceResearchResearch PersonnelResearch ProposalsResidual stateRiskStatistical ModelsSurveysSurvival RateSystemTimeTrainingUniversity of Texas M D Anderson Cancer CenterUterine CancerWeightWomanWorkantenatalbreast cancer diagnosiscancer diagnosiscancer therapycancer typecareercareer developmentchemotherapycomparative effectivenessdata registrydesignexperiencefertility barrierfertility preservationinnovationinpatient surgeryinterestmalignant breast neoplasmneoplasm registrynovelobstetric outcomesobstetrical complicationpatient orientedpatient populationpeerpopulation basedpregnantpreventprogramsprospectivepsychosocialreproductivesocialsurvival outcometumoryoung woman
项目摘要
Project Summary
Fertility is very important to many young women diagnosed with cancer. Surgery, chemotherapy, and
radiotherapy can impact fertility and pregnancy outcomes. Conversely, pregnancy at the time of cancer
diagnosis or after cancer treatment can impact survival. Despite the increasing number of young women with
gynecological or breast cancer and the importance of accurate information in guiding counseling, evidence
regarding the impact of pregnancy or assisted reproductive technologies (ART) on oncological and obstetrical
outcomes following cancer treatment remains limited. To address these knowledge gaps, Dr. Rauh-Hain plans
to conduct a population-based observational study to estimate fertility, obstetrical, and oncological outcomes in
women age 18–45 years who are diagnosed with early-stage ovarian, uterine, cervical, or breast cancer and
opt for fertility-sparing oncologic treatment. We propose a novel linkage of four unique data sources: 1)
California Cancer Registry (CCR) data, which include information about tumor characteristics, primary cancer-
directed therapy, and survival for all cancer cases diagnosed in California; 2) California Office of Statewide
Health Planning and Development (OSHPD) Birth Data, which include maternal antepartum and postpartum
hospital records for the 9 months prior to and 1 year after delivery; 3) California OSHPD inpatient and
ambulatory surgery discharge data sets, which contain patient treatment data for all inpatient and ambulatory
surgeries; and 4) the Centers for Disease Control and Prevention (CDC) National Assisted Reproductive
Technologies (ART) Surveillance System data set, which includes all ART cycles initiated in U.S. fertility
clinics. We will supplement these data with a cross-sectional survey to identify barriers preventing
reproductive-age women from achieving successful pregnancies. This study will provide information about
oncological, fertility, and obstetrical outcomes among women who become pregnant or underwent ART after a
gynecological or breast cancer diagnosis and identify barriers that prevent reproductive-age women from
achieving successful pregnancies leading to a live birth.
Dr. Rauh-Hain is a gynecologic oncologist and health services researcher at The University of Texas MD
Anderson Cancer Center. He has a particular interest in understanding the quality of care for reproductive-age
women with cancer. His long-term career goal is to become an innovative and independently funded health
services and comparative effectiveness researcher in gynecological cancer. The research program described
here is designed to complement a career development plan that includes training in advanced statistical
modeling and survey design and implementation. This award will lay the foundation for two follow-up studies:
1) a prospective multicenter cohort study to assess barriers to, and decision-making regarding, future
pregnancies in this population and 2) the use of the linked databases to expand the study to a broader
population of reproductive-age women with common cancers.
项目概要
生育能力对于许多被诊断患有癌症的年轻女性来说非常重要。手术、化疗和
放射治疗会影响生育能力和妊娠结局。相反,癌症发生时怀孕
诊断或癌症治疗后可能会影响生存。尽管患有这种疾病的年轻女性数量不断增加
妇科或乳腺癌以及准确信息在指导咨询、证据中的重要性
关于怀孕或辅助生殖技术 (ART) 对肿瘤和产科的影响
癌症治疗后的结果仍然有限。为了解决这些知识差距,Rauh-Hain 博士计划
进行一项基于人群的观察性研究,以估计生育率、产科和肿瘤结果
18-45 岁被诊断患有早期卵巢癌、子宫癌、宫颈癌或乳腺癌的女性,以及
选择保留生育能力的肿瘤治疗。我们提出了四个独特数据源的新颖链接:1)
加州癌症登记 (CCR) 数据,其中包括有关肿瘤特征、原发癌症的信息
加州诊断的所有癌症病例的定向治疗和生存率; 2) 加州全州办公室
健康规划和发展 (OSHPD) 出生数据,包括母亲产前和产后
产前 9 个月和产后 1 年的医院记录; 3) 加州 OSHPD 住院病人和
门诊手术出院数据集,其中包含所有住院患者和门诊患者的治疗数据
手术; 4) 美国疾病控制与预防中心 (CDC) 国家辅助生殖中心
技术 (ART) 监测系统数据集,其中包括美国生育力启动的所有 ART 周期
诊所。我们将通过横断面调查来补充这些数据,以确定阻碍
育龄妇女成功怀孕。这项研究将提供有关
怀孕或接受 ART 后妇女的肿瘤学、生育力和产科结果
妇科或乳腺癌诊断并确定阻止育龄妇女罹患癌症的障碍
成功怀孕并活产。
Rauh-Hain 博士是德克萨斯大学医学博士的妇科肿瘤学家和健康服务研究员
安德森癌症中心。他对了解育龄期护理质量特别感兴趣
患有癌症的女性。他的长期职业目标是成为一名创新且独立资助的健康
妇科癌症服务和比较有效性研究员。所描述的研究计划
这里旨在补充职业发展计划,其中包括高级统计培训
建模和调查设计与实施。该奖项将为两项后续研究奠定基础:
1) 一项前瞻性多中心队列研究,旨在评估未来的障碍和决策
该人群的怀孕情况以及 2) 使用链接数据库将研究扩展到更广泛的范围
患有常见癌症的育龄妇女人口。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Modeling treatment outcomes for patients with advanced ovarian cancer: Projected benefits of a test to optimize treatment selection.
- DOI:10.1016/j.ygyno.2018.02.007
- 发表时间:2018-05
- 期刊:
- 影响因子:4.7
- 作者:Davis T. Weaver;Tiana J. Raphel;A. Melamed;J. Rauh-Hain;J. Schorge;Amy B. Knudsen;P. Pandharipande
- 通讯作者:Davis T. Weaver;Tiana J. Raphel;A. Melamed;J. Rauh-Hain;J. Schorge;Amy B. Knudsen;P. Pandharipande
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
- DOI:10.1016/s1470-2045(22)00139-5
- 发表时间:2022-08
- 期刊:
- 影响因子:51.1
- 作者:Vergote, Ignace;Gonzalez-Martin, Antonio;Lorusso, Domenica;Gourley, Charlie;Mirza, Mansoor Raza;Kurtz, Jean-Emmanuel;Okamoto, Aikou;Moore, Kathleen;Kridelka, Frederic;McNeish, Iain;Reuss, Alexander;Votan, Benedicte;du Bois, Andreas;Mahner, Sven;Ray-Coquard, Isabelle;Kohn, Elise C.;Berek, Jonathan S.;Tan, David S. P.;Colombo, Nicoletta;Zang, Rongyu;Concin, Nicole;O'Donnell, Dearbhaile;Rauh-Hain, Alejandro;Herrington, C. Simon;Marth, Christian;Poveda, Andres;Fujiwara, Keiichi;Stuart, Gavin C. E.;Oza, Amit M.;Bookman, Michael A.
- 通讯作者:Bookman, Michael A.
Assessing gaps in motherhood after cancer: development and psychometric testing of the Survivorship Oncofertility Barriers Scale.
评估癌症后母亲的差距:生存肿瘤生育障碍量表的开发和心理测试。
- DOI:10.1136/ijgc-2023-004302
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Hoffman,Aubri;Denham,ChloeJosephine;Fu,Shuangshuang;Mendoza,Tito;Nitecki,Roni;Jorgensen,KirstenA;Garcia,Jose;Lamiman,Kelly;Woodard,TerriL;Rauh-Hain,JAlejandro
- 通讯作者:Rauh-Hain,JAlejandro
Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation model.
晚期卵巢癌优化化疗实施的潜在生存获益:微观模拟模型的预测。
- DOI:10.1371/journal.pone.0222828
- 发表时间:2019
- 期刊:
- 影响因子:3.7
- 作者:Lietz,AnnaP;Weaver,DavisT;Melamed,Alexander;Rauh-Hain,JoseAlejandro;Wright,JasonD;Wright,AlexiA;Knudsen,AmyB;Pandharipande,PariV
- 通讯作者:Pandharipande,PariV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose Alejandro Rauh-Hain其他文献
Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer
晚期卵巢癌在医疗机构层面采用微创间歇性肿瘤细胞减灭术的差异
- DOI:
10.1016/j.ygyno.2025.04.518 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:4.100
- 作者:
Roni Nitecki Wilke;Chi-Fang Wu;Alexa Kanbergs;Alexandra S. Bercow;Nuria Agusti;David Viveros-Carreño;Abigail S. Zamorano;Jose Alejandro Rauh-Hain;Alexander Melamed - 通讯作者:
Alexander Melamed
Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity
孕期癌症诊断与严重的母体和新生儿发病率相关。
- DOI:
10.1016/j.ajog.2024.10.022 - 发表时间:
2025-05-01 - 期刊:
- 影响因子:8.400
- 作者:
Alexa Kanbergs;Mark Clapp;Chi-Fang Wu;Alexander Melamed;Nuria Agusti;David Viveros-Carreño;Abigail S. Zamorano;Florencia Virili;Jose Alejandro Rauh-Hain;Roni Nitecki Wilke - 通讯作者:
Roni Nitecki Wilke
Jose Alejandro Rauh-Hain的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose Alejandro Rauh-Hain', 18)}}的其他基金
Health equity in fertility specialty care among cancer survivors
癌症幸存者生育专科护理的健康公平
- 批准号:
10561780 - 财政年份:2023
- 资助金额:
$ 22.78万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Research Grant














{{item.name}}会员




